ResearcherGhent University HospitalActive in the last 2 years
L.F. Abreu de Carvalho
Matched on ORCID iD 0000-0001-5821-5512; OpenAlex author ID A5062113350, A5112554170. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 5
- Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX … Co-author DOI 10.1007/s00423-026-04121-3↗
- Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenocarcinoma during surgical exploration. First author DOI 10.1016/j.hpb.2025.10.003↗
- International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
- Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicente… Co-author DOI 10.1186/s12893-025-02938-1↗
- Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities? Co-author DOI 10.1186/s12893-023-02200-6↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Frederik Christiaan Berrevoet · 4 shared papers, 2023–2026 · strength 0.96
- Paper Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenoca… DOI 10.1016/j.hpb.2025.10.003↗
- Paper Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic c… DOI 10.1007/s00423-026-04121-3↗
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1↗
- Karen Paula Geboes · 3 shared papers, 2025–2026 · strength 0.77
- Paper Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenoca… DOI 10.1016/j.hpb.2025.10.003↗
- Paper Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic c… DOI 10.1007/s00423-026-04121-3↗
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1↗
- Filip Gryspeerdt · 3 shared papers, 2023–2026 · strength 0.72
- Paper Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenoca… DOI 10.1016/j.hpb.2025.10.003↗
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1↗
- Paper Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two d… DOI 10.1186/s12893-023-02200-6↗
- Nele Vandenbussche · 1 shared paper, 2025 · strength 0.20
- Kathleen Claes · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.